Shanxi Kangbao Biological Product Co., Ltd.

This is an early study to test a new injectable drug called LP-98 in people recently diagnosed with HIV who have not yet started standard antiviral therapy. It will enroll 30 participants to receive one of three different doses, given as four shots over two months. The main goals…